Although early, the BWRX-300 looks like a potential international franchise SMR with meaningful benefits to BWX Technologies. BWXT Medical has consequential growth potential from regulatory approval of its Tc-99 platform and Ac-225, the latter depending on clinical trial results. Early indications are that alpha radiation can be a real game changer in cancer treatment as its damage proves too much for even cancers' many repair mechanisms to overcome. Seaport Global analyst Jeff Campbell on Tuesday initiated ...